Subscribe to PCE Communications
    Choose Your Subscription

    Healthcare Q4 2020

    Q4 2020 Healthcare

    M&A Transaction Trends

    Largest Transactions Closed

    • Target
    • Buyer
    • Value($mm)
    • Cytiva
    • Danaher Corporation
    • $21,251.70
    • Immunomedics, Inc.
    • Gilead Sciences, Inc.
    • $20,891.17
    • Livongo Health, Inc.
    • Teladoc Health, Inc.
    • $19,093.64
    • WellCare Health Plans, Inc.
    • Centene Corporation
    • $15,620.64
    • MyoKardia, Inc.
    • Bristol-Myers Squibb Company
    • $13,134.86
    • The Medicines Company
    • Novartis AG
    • $9,567.94
    • Momenta Pharmaceuticals, Inc.
    • Johnson & Johnson
    • $6,366.71
    • Gainwell
    • Veritas Capital Fund Management, L.L.C
    • $5,000.00
    • Forty Seven, Inc.
    • Gilead Sciences, Inc.
    • $4,951.70
    • Asklepios BioPharmaceutical, Inc.
    • Bayer Aktiengesellschaft
    • $4,000.00

     

    Source S&P Capital IQ as of 1/13/2021 and PCE Proprietary Data

    New call-to-action

    Contacts

    Michael Poole

    Orlando Office

    407-621-2112

    David Jasmund

    Orlando Office

    407-621-2111

    David Jasmund

     

    David Jasmund

    Investment Banking | ESOP

    Orlando Office

    407-621-2111 (direct)

    djasmund@pcecompanies.com

    Connect
    407-621-2111 (direct)

    407-621-2199 (fax)

    Eric Zaleski

     

    Eric Zaleski

    Investment Banking | ESOP

    Chicago Office

    847-239-2466 (direct)

    ezaleski@pcecompanies.com

    Connect
    847-239-2466 (direct)

    407-621-2199 (fax)

    Melissa Ritter

     

    Melissa Ritter

    Investment Banking

    Orlando Office

    407-621-2128 (direct)

    mritter@pcecompanies.com

    Connect
    407-621-2128 (direct)

    407-621-2199 (fax)

    Michael Rosendahl

     

    Michael Rosendahl

    Investment Banking

    New York Office

    201-444-6280 Ext 1 (direct)

    mrosendahl@pcecompanies.com

    Connect
    201-444-6280 Ext 1 (direct)

    407-621-2199 (fax)

    Will Stewart

     

    Will Stewart

    Investment Banking | ESOP

    Orlando Office

    407-621-2124 (direct)

    wstewart@pcecompanies.com

    Connect
    407-621-2124 (direct)

    407-621-2199 (fax)

    whitcomb-woody

     

    Woody Whitcomb

    Investment Banking

    Orlando Office

    407-621-2113 (direct)

    wwhitcomb@pcecompanies.com

    Connect
    407-621-2113 (direct)

    407-621-2199 (fax)

    poole_michael

     

    Michael Poole

    Investment Banking

    Orlando Office

    407-621-2112 (direct)

    mpoole@pcecompanies.com

    Connect
    407-621-2112 (direct)

    407-621-2199 (fax)

    vogt-paul

     

    Paul Vogt

    Valuation

    Atlanta Office

    678-641-4760 (direct)

    pvogt@pcecompanies.com

    Connect
    678-641-4760 (direct)

    407-621-2199 (fax)

    Mackenzie Moran

     

    Mackenzie Moran

    Investment Banking

    New York Office

    201-444-6280 Ext 3 (direct)

    mmoran@pcecompanies.com

    Connect
    201-444-6280 Ext 3 (direct)

    407-621-2199 (fax)

    Isabel Carta

     

    Isabel Carta

    Investment Banking

    Orlando Office

    407-621-2149 (direct)

    icarta@pcecompanies.com

    Connect
    407-621-2149 (direct)

    407-621-2199 (fax)

    Philipp Seubert

     

    Philipp Seubert

    Investment Banking

    New York Office

    201-444-6280 Ext 4 (direct)

    pseubert@pcecompanies.com

    Connect
    201-444-6280 Ext 4 (direct)

    407-621-2199 (fax)

    Pearl-Rachel 667 x 667

     

    Rachel Pearl

    Valuation

    Orlando Office

    407-621-2140 (direct)

    rpearl@pcecompanies.com

    Connect
    407-621-2140 (direct)

    407-621-2199 (fax)

    R Winston 667 x 667

     

    Richard Winston

    Valuation

    Atlanta Office

    404-994-4650 (direct)

    rwinston@pcecompanies.com

    Connect
    404-994-4650 (direct)

    407-621-2199 (fax)

    Thomas Harrington

     

    Thomas Harrington

    Investment Banking

    Orlando Office

    407-621-2145 (direct)

    tharrington@pcecompanies.com

    Connect
    407-621-2145 (direct)

    407-621-2199 (fax)

    Data Assumptions

    This report represents transaction activity as mergers & acquisitions, consolidations, restructurings and spin-offs. Targets are defined as U.S. Based companies with either foreign or U.S. based buyers. Transaction information provided is based on closed dates only.

    Glossary

    EBIT - Earnings Before Interest and Taxes
    EBITDA - Earnings Before Interest, Taxes, Depreciation, Amortization
    LTM - Last Twelve Months
    TEV - Total Enterprise Value

    Sources:

    1. "Current Employment Statistics Highlights November 2020." Current Employment Statistics Highlights. U.S. Bureau of Labor Statistics, December 04th 2020.
    2. Owermohle, Sarah. "U.S. Buys Another 100M Doses of Pfizer-BioNTech Coronavirus Vaccine." POLITICO. POLITICO LLC, December 23rd 2020.
    3. O'Brien, Jack. "'Difficult Winter Ahead' for Hospitals Amid COVID-19 Surge." HealthLeaders. HealthLeaders Media, December 21st. 2020.
    4. Lagasse, Jeff. "Federal Judge Blocks Attempt from the FTC to Halt the Jefferson-Einstein Merger." Healthcare Finance News. HIMSS Media, December 11th 2020.
    5. Jercich, Kat. "Philips Will Buy Remote Patient Monitoring Company BioTelemetry." Healthcare IT News. HIMSS Media, December 21st. 2020.
    6. Sanchez, Mark. "Telehealth Use Soars during the Pandemic, Here to Stay." MiBiz. MiBiz, January 03rd 2021.
    7. Baker, Stephanie, John Lauerman, and Tom Loh. "AstraZeneca to Buy Alexion for $39 Billion in Rare-Disease Push." Bloomberg.com. Bloomberg, December 12th 2020. Web. January 06th 2021.
    8. Spector, Mike. "OxyContin Maker Purdue Pharma Pleads Guilty to Criminal Charges." Reuters. Thomson Reuters, November 24th 2020.

    Please Share This